title: A novel treatment of central serous chorioretinopathy with topical anti-inflammatory therapy.
abstract: A 45-year-old Caucasian female with diagnosis of central serous chorioretinopathy (CSCR) did not improve on conventional observational approach. She was not willing to proceed with photocoagulation or photodynamic therapy. An unconventional approach of topical anti-inflammatory (ketorolac, dexamethasone and hydrocortisone) preparation was prescribed. The course of her CSCR responded well on this unconventional treatment, but relapsed on cessation or tapering of treatment. After 18 weeks of treatment with a gradual taper, her condition resolved. The present case highlights an alternative but unconventional treatment of CSCR with prolonged use of anti-inflammatories.
authors.affiliation: Dubbo Eye Centre, Dubbo, New South Wales, Australia. fong_cf@yahoo.com
authors.forename: Chee-Foong
authors.initials: CF
authors.lastname: Chong
authors.forename: David
authors.initials: D
authors.lastname: Yang
authors.forename: Thuan Q
authors.initials: TQ
authors.lastname: Pham
authors.forename: Henry
authors.initials: H
authors.lastname: Liu
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D056833:Central Serous Chorioretinopathy / Q000175:diagnosis / Q000188:drug therapy*; D003907:Dexamethasone / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage*; D020910:Ketorolac / Q000008:administration & dosage*; D008875:Middle Aged; D009883:Ophthalmic Solutions; D012008:Recurrence; D041623:Tomography, Optical Coherence; D014792:Visual Acuity / Q000187:drug effects
chemical_list: D000893:Anti-Inflammatory Agents; D009883:Ophthalmic Solutions; D003907:Dexamethasone; D006854:Hydrocortisone; D020910:Ketorolac